STE
Status-Quo-PlayerSteris
$224.85
+1.02%
as of 13 Apr
Power Core
The moat in one sentence: Steris's power derives from the integration of installed capital equipment, proprietary consumables, service contracts, and compliance documentation into a single ecosystem that hospitals and pharmaceutical manufacturers find prohibitively costly and risky to unbundle.
Direction of Movement
Steady Upward Compounding Across All Three Segments
ROC 200
-9.3%
STE
Steris
$224.85
+1.02%
as of 13 Apr
DCF Fair Value: $118.58
mOS zones are proprietary L17X overlays and do not constitute trading signals or investment advice.
Company Profile
STERIS plc is a leading provider of infection prevention and other surgical products and services in the healthcare sector. The company develops, manufactures, and distributes a comprehensive range of sterile processing equipment, consumables, and services designed to help healthcare facilities maintain sterility and safety standards. Its offerings include sterilization systems, washing and decontamination equipment, surgical tables, lights, and endoscopes, along with maintenance and support services. STERIS plc serves hospitals, ambulatory surgery centers, and pharmaceutical manufacturers through its core segments: Healthcare, Applied Sterilization Technologies, and Life Sciences. These segments enable the delivery of critical solutions for reprocessing medical devices, sterilizing single-use medical products, and supporting biopharmaceutical production. Founded in 1985 and headquartered in Dublin, Ireland, STERIS plc plays a vital role in enhancing patient safety and operational efficiency across global healthcare and life sciences markets.